학술논문

The effect of combining the glucagon-like peptide-1 (GLP-1) agonist semaglutide with very-low calorie diet (VLCD) on body weight, body composition and glycaemic outcomes in people with type 2 diabetes: Interim results
Document Type
Journal
Source
DIABETIC MEDICINE; APR 2023, 40 1p. Supplement: 1
Subject
Language
English
ISSN
14645491